ArticleCancer biology & therapy2013

Galectin-3 inhibition sensitizes human renal cell carcinoma cells to arsenic trioxide treatment.

Yangyang Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.